Dextenza Approved for Ocular Itching Associated With Allergic Conjunctivitis
The approval was based on data from three phase 3 studies that evaluated the efficacy and safety of Dextenza in patients with allergic conjunctivitis.
Ocular Allergy/Inflammation
FDA Approves Generic Version of Durezol
Difluprednate Ophthalmic Emulsion 0.05% is an AB-rated generic equivalent of Durezol.
Verkazia Approved for Vernal Keratoconjunctivitis
The approval was based on data from two randomized, multicenter, double-masked, vehicle-controlled trials that evaluated the efficacy and safety of Verkazia in patients with VKC.
Pataday Once Daily Relief Extra Strength Available Over-the-Counter
Pataday Once Daily Relief Extra Strength is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Eysuvis Now Available For Dry Eye Disease
Eysuvis (loteprednol etabonate ophthalmic suspension) is now available for the short-term treatment of the signs and symptoms of dry eye disease.
Eysuvis Approved for Dry Eye Disease
Results from 4 clinical trials showed that treatment with Eysuvis was associated with significant improvements in both the signs and symptoms of dry eye disease.
Cyclosporine Eyedrops Under Review for Vernal Keratoconjunctivitis
Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye.
Preservative-Free Alaway Gets FDA Approval for OTC Use
The new formulation does not contain benzalkonium chloride.
New Drug Product: Durysta
This slideshow shows drug information for Durysta. Click here for the complete Durysta monograph.
Olopatadine 0.7% Eye Drops Approved for Sale Over-the-Counter
The FDA has approved Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride 0.7%; Alcon) ophthalmic solution, formerly prescribed as Pazeo®, for sale over-the-counter.
